EN
cn 
1kg/bag; 25kg/drum
Address
中国.山东聊城开发区创业大厦
Chitosan oligosaccharide (COS) represents a class of natural polymers that holds therapeutic promise in several diseases due to not only its physiochemical properties including water-solubility and low viscosity but also its favorable pharmacological properties including good pharmacokinetics and safety profiles and diverse beneficial biological activities. Activation of AMPK and inhibition of inflammatory signaling pathways including NF-κB and MAPK pathways are recognized as major mechanisms responsible for several effects of Chitosan oligosaccharide (COS) including anti-inflammation, anti-cancer, and anti-diabetes.
Synonym
CHITOSANOLIGOSACCHARIDELACTATE; Chitosan2-hydroxypropanoate(ester); Chitosanlactate(ester); Chitosanoligosaccharide(COS); ChitosanoliChemicalbookgosaccharidelactateaverageMn5,000; ChitosanoligosaccharideHCl; Chitosanoligosaccharide,chito-oligosaccharide; ChitosanOlibosaccharide
Appearance | Yellow Or Light Yellow Powder Solid, No Smell, No Visible Impurities |
Content | ≥80% |
Molecular Weight | ≤10000Da |
Viscosity | Meets The Requirements |
Moisture | ≤10% |
Ash Content | ≤2% |
Ph | 5~7 |
Acid–insoluble Substance | ≤2.0% |
1kg/bag; 25kg/drum
Store in a cool, dry and ventilated place.
2 - 8 °C
Nutrients; pharmaceutical raw materials; nutrition fortifiers
By modulating several signaling proteins/pathways including NF-κB, AMPK, mTOR, caspase-3, CD147, MMP-2, MMP-9, and VEGF.
Including ascites, bladder cancer, prostate cancer, lung cancer, liver cancer, leukemia, cervical cancer and colorectal cancer.
